With 25 FDA- and CE-cleared indications and suitability for virtually all skin types, ADVATx is designed to become the cornerstone of your aesthetic practice. It delivers safe, effective, year-round treatments for a diverse patient base—including those with skin of colour—setting a new standard in laser therapy.
ADVATx sets the gold standard with its dual wavelengths, each designed to target specific chromophores at optimal depths to support overall dermal health.
The 589nm wavelength penetrates up to 1.25mm and is selectively absorbed by oxyhaemoglobin. It targets C. acnes bacteria and pigmented lesions, making it highly effective for treating acne, rosacea, vascular concerns, pigmentation, and melasma.
The 1319nm wavelength penetrates up to 2mm and is primarily absorbed by water, making it particularly safe for darker skin types. It stimulates fibroblasts and boosts collagen production for non-ablative skin resurfacing, while also delivering controlled thermal energy to sebaceous glands to help regulate oil and sebum production. When combined with the 589nm wavelength, it provides a comprehensive and effective solution for active acne.
With presets for the most common treatments and advanced operating modes, ADVATx features an intuitive interface and simple, user-friendly controls. Its industry-leading safety profile and low risk of side effects give practitioners the confidence to delegate treatments, knowing patient safety remains the top priority.
Discover how ADVATx can transform your clinic—enquire today.
ADVATx delivers both 589nm and 1319nm wavelengths through a single ergonomic, lightweight handpiece. Treatment can be delivered using either a single-spot or fractionated mode, with the added benefit of a sapphire tip for passive cooling to enhance patient comfort.
Practices worldwide have adopted ADVATx, treating thousands of patients with minimal side effects such as bruising, purpura, or swelling. Powered by patented PulSync technology, a SoftPulse delivery system, and dual 589nm and 1319nm wavelengths, ADVATx enables practitioners to deliver tailored treatments for vascular conditions, acne, rosacea, scarring, melasma, pigmentation, and more.
Treatments require no topical anaesthetic and involve no social downtime, making them both convenient and patient-friendly. The clinical efficacy of ADVATx’s dual wavelengths is well established, with ongoing research led by leading dermatologists around the world.
